Noscapine
In clinical developmentAlso known as (-)-narcotine, alpha-Narcotine, Noscapina, Noscapinum.
Recent clinical, regulatory, research and industry developments relating to this drug.
Behavioral and Neurological Effects of Edaravone and Noscapine in Albino Wistar Rats.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes3
Journals, researchers & institutions
- Experimental aging research1
- Doshi GM1
- Godad AP1
- Hafizur Rehman MR1
- SVKM's Dr Bhanuben Nanavati College of Pharmacy1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 2 of the same disease areas as Noscapine in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials